Clinical implications of Girdin and PI3K protein expression in breast cancer.
about
Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a HydraMultimodular biosensors reveal a novel platform for activation of G proteins by growth factor receptors.miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating GirdinGirdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon CancerPrognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers.Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer.Clinical implications of Girdin protein expression in glioma.
P2860
Q26801694-E61F59AA-AB5C-4C51-881A-83C3261CDACBQ35156947-4F32C7DA-D430-4060-903F-626A1BFB8E4DQ36591312-EF1D066D-9305-4F48-A1F2-99E11F05C1C7Q37100057-62275816-31F4-45FB-8FBE-A41549C33115Q42705481-2C8F4D2C-BD78-4D3D-9C34-076677304AAAQ49875019-CE75E13B-D9D3-4A2B-B77E-B3677522CB95Q54518510-9D6C1676-03CF-4BF5-930F-6448D8F6CC52
P2860
Clinical implications of Girdin and PI3K protein expression in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical implications of Girdin and PI3K protein expression in breast cancer.
@en
type
label
Clinical implications of Girdin and PI3K protein expression in breast cancer.
@en
prefLabel
Clinical implications of Girdin and PI3K protein expression in breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Clinical implications of Girdin and PI3K protein expression in breast cancer.
@en
P2093
P2860
P304
P356
10.3892/OL.2013.1249
P577
2013-03-12T00:00:00Z